Investigation into the immunological effects of miltefosine, a new anticancer agent under development
- 1 September 1991
- journal article
- research article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 117 (5) , 403-408
- https://doi.org/10.1007/bf01612758
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Evidence of a role for NK cells in oxazaphosphorine-mediated tumor regressionZeitschrift für Krebsforschung und Klinische Onkologie, 1989
- Characterization of the antitumor activity of hexadecylphosphocholine (D 18506)European Journal of Cancer and Clinical Oncology, 1988
- Immunomodulatory and therapeutic properties of alkyl lysophospholipids in miceLipids, 1987
- Differential effects of ether lipids on the activity and secretion of interleukin‐1 and interleukin‐2Lipids, 1987
- Generation of antigen specific cytotoxic T lymphocytes (CTL) directed against Class II molecules expressed by activated T cellsJournal of Immunological Methods, 1985
- Oxazaphosphorines as biological response modifiers-experimental and clinical perspectivesCancer Treatment Reviews, 1985
- Tumor Cytotoxicity of Human Macrophages After Incubation With Synthetic Analogues of 2-Lysophosphatidylcholine2JNCI Journal of the National Cancer Institute, 1984
- Anti-tumor action of alkyl-lysophospholipids (Review).1981
- Steigerung der Phagocytose von Peritonealmakrophagen durch LysolecithinZeitschrift für Naturforschung B, 1964